Advancing Knee Joint Preservation: Innovations in Cartilage Repair and Meniscus Preservation
Abstract:
Cartilage cannot effectively heal itself, leading untreated damage to accelerate into widespread joint degeneration. By restoring natural biomechanics early through advanced innovations in cartilage regeneration and meniscus preservation, new clinical approaches successfully delay or prevent severe osteoarthritis and joint replacement, ultimately preserving long-term patient mobility and improving healthspan.
1. Articular cartilage has limited natural healing capacity. What are the major challenges in treating cartilage injuries, and why is early intervention critical to preventing progressive knee joint degeneration?
Cartilage is the smooth covering that allows the knee to glide and protects the bone underneath. Unlike skin, cartilage has no direct blood supply (avascular) and very limited ability to repair itself. The challenge is to restore a surface that can withstand years of movement and loading. We must also address anything putting that surface under strain, such as a torn meniscus or an unstable knee. Left untreated, a damaged area can enlarge and place more stress on the surrounding cartilage. Early assessment gives us more options, including rehabilitation and selected repair procedures, before damage becomes widespread. Early intervention does not automatically mean surgery; it means addressing the right problem promptly.
2. How has the approach to knee joint preservation evolved over the past decade, particularly in shifting the focus from managing symptoms to restoring natural joint function and biomechanics?
We increasingly look at why the knee is struggling, rather than treating pain alone. Cartilage, the meniscus, ligaments, muscles, and leg alignment all work together. Repairing one structure without considering the others can leave the underlying problem unresolved. There is also greater emphasis on preservation, which is to keep healthy tissue and protect the bone beneath the cartilage. This bone supports the cartilage, and most repairs done later are built on it. Microfracture is a procedure that makes small holes in this bone. If it does not work, it can burn bridges for future repair options as the bone is damaged. For this reason, I am cautious about unnecessary microfracture. The goal is to restore comfortable, useful movement while keeping future treatment choices open, with rehabilitation built into the plan.
3. What are the most promising advancements in cartilage repair and regeneration today? How are techniques such as autologous chondrocyte implantation (ACI), matrix-induced autologous chondrocyte implantation (MACI) and osteochondral transplantation changing treatment possibilities?
We now have more ways to repair a damaged patch of cartilage. ACI involves growing a patient’s own cartilage cells and returning them to the injured area. MACI places these cells on a supporting scaffold, which acts as a framework for repair. AMIC skips the growing step, so it takes a single operation. Instead, I remove the unhealthy cartilage and release cells from the bone beneath to help new tissue grow in its place. A collagen membrane placed over the area protects this tissue as it forms. AMIC+ adds concentrated cells from the patient’s bone marrow to the same procedure. When the bone under the cartilage is damaged too, osteochondral transplantation moves both layers together, using tissue from the patient’s own knee or from a donor. These approaches have expanded treatment choices, particularly for larger or deeper defects. They are most useful in selected patients, rather than every arthritic knee. The best option depends on the injury and the condition of the whole knee.
4. Biological therapies, including platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC) and other regenerative approaches, are gaining attention in orthopaedics. What does current clinical evidence suggest about their effectiveness in cartilage repair and joint preservation?
These treatments use components of the patient’s own blood or bone marrow to support healing. Platelet-rich plasma, or PRP, can help reduce pain and improve function in some patients with knee osteoarthritis (OA), although results differ across studies. Bone marrow aspirate concentrate, or BMAC, is also being studied as an injection, but it has not consistently done better than PRP, which needs only a blood draw. In AMIC+, I place BMAC directly on the damaged area rather than injecting it into the joint. Published results for this approach include less pain and better knee function lasting several years, with MRI scans showing cartilage repair. We must distinguish feeling better from actually growing durable, healthy cartilage, because evidence that injections alone regenerate it remains weaker than evidence for symptom relief. I see these treatments as possible additions to a carefully chosen plan, with clear explanations of their benefits and limitations.
5. The meniscus plays a crucial role in load distribution, shock absorption and knee stability. What are the long-term consequences of meniscus removal or inadequate repair, and why has meniscus preservation become a priority in modern orthopaedic practice?
The meniscus is a crescent-shaped cushion that spreads weight across the knee. Removing part of it might relieve symptoms, but the procedure also leaves the joint surfaces carrying more pressure. Over time, this can increase the risk of cartilage damage and arthritis. A badly torn meniscus may lose its protective function even if the tissue is still present. This is why I prioritise preserving and repairing it where possible. Some tears cannot be repaired, and some repaired tears do not heal. The aim is to retain as much useful tissue and natural knee function as possible.
6. What advances in meniscus repair techniques, including root repair, complex tear repair and biologically augmented procedures, are helping surgeons preserve meniscal tissue and improve healing outcomes?
Better stitching and fixation techniques now allow us to repair tears once considered difficult to save. Root repair reattaches the meniscus to the bone, helping it spread weight again. For selected complex tears, I also use a biologically augmented approach called arthroscopic matrix-based meniscus repair, or AMMR. Through keyhole surgery, the tear is stitched and supported with a collagen scaffold, a framework that’s intended to help it heal. The aim is to preserve tissue that might otherwise be removed. Results are encouraging, although comparative evidence is still developing. Tissue quality, knee stability, and careful rehabilitation remain essential to success.
7. Patient selection is critical to the success of joint-preserving procedures. Which clinical factors, such as age, activity level, cartilage damage severity, alignment and associated injuries, determine whether a patient is suitable for cartilage repair or meniscus preservation?
Age matters, because healing tends to be more reliable in younger patients, but I look beyond it to the condition of the knee and how active the patient wants to be. A small damaged area surrounded by healthy cartilage is very different from widespread arthritis. The size and depth of the injury, the underlying bone, leg alignment, and ligament stability all matter. For meniscus preservation, the location of the tear and the quality of the tissue are key, as tears in the outer part, which has a better blood supply, tend to heal better. Smoking, excess body weight, and poor general health can also reduce the chances of a good recovery. Equally important is whether the patient can commit to rehabilitation. A suitable procedure should address the cause of their symptoms and offer a realistic chance of returning to the activities they care about.
8. How are advanced imaging technologies, including MRI mapping, quantitative cartilage assessment and arthroscopic evaluation, improving the diagnosis, staging and treatment planning of cartilage and meniscal injuries?
A standard MRI helps us see where cartilage is damaged and whether the meniscus, ligaments, or underlying bone are affected. Newer techniques, such as T2 relaxation value (T2RV) mapping, provide clues about the cartilage’s internal structure and water content. This can help us study early changes and monitor repair, rather than simply looking at the shape of the surface. However, a better scan result does not automatically mean normal cartilage has returned. We interpret these findings alongside symptoms, examination, and standing X-rays. When surgery is appropriate, a small camera inside the knee allows direct assessment and grading of the damaged tissues.
9. Knee joint degeneration often involves multiple factors, including cartilage defects, meniscal damage, ligament instability and mechanical misalignment. How important is a comprehensive, biomechanical approach that addresses these underlying issues together?
Addressing these issues together is essential, because a cartilage repair needs the right conditions to survive. If the leg is poorly aligned, too much weight may pass through the repaired area. If a ligament is torn or the meniscus is damaged, the knee may remain unstable or poorly cushioned. These problems can continue to overload a new repair. We therefore assess how the whole knee works and, where needed, correct alignment, restore stability, repair the meniscus, or treat damage to the bone beneath the cartilage. Depending on the patient’s needs and what is safest for surgery and recovery, I may combine these procedures or stage them.
10. What role are emerging technologies such as tissue engineering, biomaterial scaffolds, 3D bioprinting and cell-based therapies expected to play in the next generation of cartilage regeneration and meniscus repair?
I expect these technologies to bring repairs closer to the knee’s original tissue. Much of this depends on scaffolds, which act as temporary frameworks that support cells while tissue develops. Better scaffold materials could help us recreate the different qualities of cartilage, the bone underneath it, and the meniscus. Beyond the right materials, I believe cartilage treatment should be bespoke, so I am particularly interested in matching a scaffold’s shape, thickness, and strength to the patient’s damaged area. Three-dimensional bioprinting, which places cells and materials in precise patterns, might eventually make this kind of matching possible. Once the scaffold fits, cell-based treatments added to it may improve how well the new tissue heals. For all of these approaches, the challenge is making this tissue join securely with its surroundings and survive everyday loading. Many of these possibilities still need testing in patients.
11. Beyond surgical intervention, how important are rehabilitation protocols, muscle strengthening, weight management and activity modification in protecting repaired cartilage and meniscal tissue and ensuring long-term joint health?
Surgery creates an opportunity for healing, but rehabilitation helps turn the opportunity into lasting function. To build this function, I emphasise strength, range of movement, and balance, including the body’s ability to sense and control joint position. These exercises, along with weight-bearing, must progress gradually according to the type of repair and how the patient is recovering. Body weight also affects the load on the knee, so managing excess weight can reduce pressure on it. For the same reason, some activities may need temporary adjustment, but the longer-term goal is confident, sustainable movement. When this movement includes sports, the return should depend on healing, symptoms, strength, and control, rather than a fixed date alone. Throughout this process, recovery is a shared effort: the patient puts in the work, and our team guides it.
12. What are the most significant challenges currently limiting the widespread adoption of advanced knee preservation procedures? Are cost, clinical evidence, surgical expertise or access to specialized treatment among the major barriers?
All four are real barriers, and they are closely connected. They start with what many advanced procedures require: laboratory-grown cells, donor tissue, specialised equipment, or surgeons with particular training. These requirements make the procedures expensive and limit them to centres with the right expertise, so clearer referral pathways and wider training would help more patients reach these centres. Even then, recovery adds its own costs, such as time away from work and regular physiotherapy that not everyone can easily access. Because these costs continue after surgery, rehabilitation should be counted as part of the treatment. With the full cost in view, we need to know which approach offers the best value for each patient. However, studies often look at different injuries and test different treatments, so their results are difficult to weigh against each other. Better long-term tracking of outcomes would show which approaches work best over time. We must judge these outcomes by patients’ lasting function and quality of life, not just by how a scan looks.
13. How can clinicians better identify patients at risk of early osteoarthritis and intervene before irreversible joint damage occurs? What changes are needed to encourage a more proactive, joint-preservation-focused model of orthopaedic care?
Knee pain is a symptom, not a diagnosis, so the signs around it matter. Repeated swelling, giving way, or a gradual loss of function deserves assessment, particularly after a previous injury. GPs can help by recognising these signs and referring patients whose problems may still be treatable before damage becomes extensive. Once a patient is referred, examination and standing X-rays are often useful starting points, with MRI used when it can guide treatment. When early changes are found, exercise, weight management, and timely rehabilitation are central to managing them. To deliver this care sooner, we need better links between GPs, physiotherapists, and surgeons. In a more proactive model, we act on signs that affect function, rather than on scan findings alone.
14. Looking ahead over the next five to ten years, which innovations or clinical developments do you believe will have the greatest impact on cartilage regeneration, meniscus preservation and delaying or preventing knee replacement surgery?
Over the next five to 10 years, I expect bespoke scaffolds designed around each patient’s injury, tissue quality, and loading needs to become an important direction. Better meniscus repair and earlier diagnosis should also expand preservation options. My longer-term “cartilage utopia” would be a preventive treatment given before damage develops, rather like the protective idea behind a vaccine. No such treatment exists yet, so this is an aspiration. For now, any new approach must keep the knee working well for longer and delay the need for knee replacement, which remains an important option for advanced arthritis.